Hepion Pharmaceuticals, Inc.Hepion Pharmaceuticals, Inc.Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.21 M‬USD
−9.41USD
‪−48.93 M‬USD
‪5.47 M‬
Beta (1Y)
−0.47

About Hepion Pharmaceuticals, Inc.

CEO
John T. Cavan
Headquarters
Edison
Employees (FY)
22
Founded
2013
FIGI
BBG005Y0S0J9
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HEPA is 1.07 USD — it has increased by 2.39% in the past 24 hours. Watch Hepion Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Hepion Pharmaceuticals, Inc. stocks are traded under the ticker HEPA.
HEPA stock has risen by 11.46% compared to the previous week, the month change is a 12.30% fall, over the last year Hepion Pharmaceuticals, Inc. has showed a 89.47% decrease.
HEPA reached its all-time high on Oct 5, 2015 with the price of 70,336.00 USD, and its all-time low was 0.90 USD and was reached on Jun 17, 2024. View more price dynamics on HEPA chart.
See other stocks reaching their highest and lowest prices.
HEPA stock is 5.94% volatile and has beta coefficient of −0.47. Track Hepion Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hepion Pharmaceuticals, Inc. there?
Today Hepion Pharmaceuticals, Inc. has the market capitalization of ‪5.86 M‬, it has increased by 3.00% over the last week.
Yes, you can track Hepion Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Hepion Pharmaceuticals, Inc. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
HEPA net income for the last quarter is ‪−2.85 M‬ USD, while the quarter before that showed ‪−11.06 M‬ USD of net income which accounts for 74.20% change. Track more Hepion Pharmaceuticals, Inc. financial stats to get the full picture.
No, HEPA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 13, 2024, the company has 22.00 employees. See our rating of the largest employees — is Hepion Pharmaceuticals, Inc. on this list?
Like other stocks, HEPA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hepion Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hepion Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hepion Pharmaceuticals, Inc. stock shows the sell signal. See more of Hepion Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.